Inventor
WINDSOR WILLIAM T
US13 patents
⚠️ This page may combine multiple inventors who share the name “WINDSOR WILLIAM T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
12 patentsUS6451982B1Sep 17, 2002
Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
SCHERING CORP35 citations90
US6251583B1Jun 26, 2001
Peptide substrates for HCV NS3 protease assays
SCHERING CORP45 citations90
US6056957AMay 2, 2000
Humanized monoclonal antibodies against human interleukin-5
SCHERING CORP48 citations90
US6539309B1Mar 25, 2003
Crystallizable farnesyl protein transferase compositions, crystals thereby obtained, and methods for use
SCHERING CORP8 citations73
US6645966B2Nov 11, 2003
Treatment of malaria with farnesyl protein transferase inhibitors
SCHERING CORP5 citations61
US7776589B1Aug 17, 2010
Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)
SCHERING CORP2 citations58
US7067273B2Jun 27, 2006
Peptide substrates of a proteolytic ADAM33 polypeptide and assays using the same
SCHERING CORP3 citations57
US6380172B1Apr 30, 2002
Monomeric lipophilic oligosaccharide antibiotic compositions
SCHERING CORP3 citations57
US8034907B2Oct 11, 2011
Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
SCHERING CORP0 citations49
US7632920B2Dec 15, 2009
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
SCHERING CORP0 citations49
US7446195B2Nov 4, 2008
High affinity thiophene-based and furan-based kinase ligands
SCHERING CORP1 citations49
US7511063B2Mar 31, 2009
High affinity quinoline-based kinase ligands
SCHERING CORP0 citations39